ArticleClinical epigenetics2019

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients.

Begoña Pineda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.